Page last updated: 2024-08-23

cabergoline and Abnormal Movements

cabergoline has been researched along with Abnormal Movements in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T	1
Belkhir, S; Di Paolo, T; Dridi, M; Grégoire, L; Meltzer, LT; Morissette, M; Ouattara, B; Samadi, P	1
Deuschl, G; Fox, GC; Gordin, A; Roscher, T; Schremmer, D; Vaitkus, A	1
Baas, HK; Schueler, P	1

Trials

2 trial(s) available for cabergoline and Abnormal Movements

Article	Year
Efficacy and tolerability of Entacapone versus Cabergoline in parkinsonian patients suffering from wearing-off. Movement disorders : official journal of the Movement Disorder Society, 2007, Aug-15, Volume: 22, Issue:11 Topics: Aged; Analysis of Variance; Antiparkinson Agents; Cabergoline; Catechols; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Dyskinesias; Ergolines; Female; Humans; Male; Medical Records; Middle Aged; Nitriles; Parkinson Disease; Psychiatric Status Rating Scales; Surveys and Questionnaires	2007
Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease. European neurology, 2001, Volume: 46 Suppl 1 Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Dyskinesias; Ergolines; Female; Humans; Male; Motor Activity; Parkinson Disease; Quality of Life; Sleep; Time	2001

Article

Year

Efficacy and tolerability of Entacapone versus Cabergoline in parkinsonian patients suffering from wearing-off.

Movement disorders : official journal of the Movement Disorder Society, 2007, Aug-15, Volume: 22, Issue:11

Topics: Aged; Analysis of Variance; Antiparkinson Agents; Cabergoline; Catechols; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Dyskinesias; Ergolines; Female; Humans; Male; Medical Records; Middle Aged; Nitriles; Parkinson Disease; Psychiatric Status Rating Scales; Surveys and Questionnaires

2007

Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease.

European neurology, 2001, Volume: 46 Suppl 1

Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Dyskinesias; Ergolines; Female; Humans; Male; Motor Activity; Parkinson Disease; Quality of Life; Sleep; Time

2001

Other Studies

2 other study(ies) available for cabergoline and Abnormal Movements

Article	Year
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report. The Bulletin of Tokyo Dental College, 2013, Volume: 54, Issue:3 Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture	2013
Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias. Journal of molecular neuroscience : MN, 2009, Volume: 38, Issue:2 Topics: Animals; Autoradiography; Behavior, Animal; Benserazide; Benzoxazoles; Cabergoline; Corpus Striatum; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Ergolines; Female; Humans; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Piperidines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate	2009

Article

Year

Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.

The Bulletin of Tokyo Dental College, 2013, Volume: 54, Issue:3

Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture

2013

Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.

Journal of molecular neuroscience : MN, 2009, Volume: 38, Issue:2

Topics: Animals; Autoradiography; Behavior, Animal; Benserazide; Benzoxazoles; Cabergoline; Corpus Striatum; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dyskinesias; Ergolines; Female; Humans; Levodopa; Macaca fascicularis; MPTP Poisoning; Ovariectomy; Piperidines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate

2009